West Pharmaceutical Services, Inc. WST
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 464.10M | 435.80M | 521.40M | 791.30M | 628.50M |
| Total Receivables | 763.30M | 729.20M | 701.00M | 586.30M | 652.50M |
| Inventory | 464.70M | 447.40M | 452.60M | 443.90M | 438.00M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 124.40M | 195.10M | 151.80M | 156.70M | 104.30M |
| Total Current Assets | 1.82B | 1.81B | 1.83B | 1.98B | 1.82B |
|
|
|||||
| Total Current Assets | 1.82B | 1.81B | 1.83B | 1.98B | 1.82B |
| Net Property, Plant & Equipment | 1.81B | 1.82B | 1.85B | 1.88B | 1.87B |
| Long-term Investments | 108.70M | 108.70M | 109.20M | 109.90M | 110.60M |
| Goodwill | 108.70M | 108.70M | 109.20M | 109.90M | 110.60M |
| Total Other Intangibles | 6.20M | 6.40M | 7.00M | 7.70M | 8.90M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 105.60M | 121.90M | 111.20M | 83.80M | 68.50M |
| Total Assets | 4.06B | 4.08B | 4.11B | 4.27B | 4.11B |
|
|
|||||
| Total Accounts Payable | 249.40M | 252.70M | 252.30M | 253.70M | 255.80M |
| Total Accrued Expenses | 162.90M | 131.10M | 119.20M | 214.60M | 111.80M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 20.90M | 22.30M | 22.90M | 24.20M | 22.90M |
| Total Finance Division Other Current Liabilities | 211.10M | 234.40M | 279.60M | 162.40M | 244.90M |
| Total Other Current Liabilities | 211.10M | 234.40M | 279.60M | 162.40M | 244.90M |
| Total Current Liabilities | 644.30M | 640.50M | 674.00M | 654.90M | 635.40M |
|
|
|||||
| Total Current Liabilities | 644.30M | 640.50M | 674.00M | 654.90M | 635.40M |
| Long-Term Debt | 202.90M | 202.90M | 202.80M | 202.80M | 202.70M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 90.10M | 91.30M | 95.30M | 99.20M | 77.40M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 155.20M | 151.50M | 147.30M | 137.10M | 138.80M |
| Total Liabilities | 1.09B | 1.09B | 1.12B | 1.09B | 1.05B |
|
|
|||||
| Common Stock & APIC | 18.80M | 18.80M | 18.80M | 18.80M | 18.80M |
| Retained Earnings | 4.82B | 4.62B | 4.48B | 4.37B | 4.26B |
| Treasury Stock & Other | -1.87B | -1.65B | -1.50B | -1.22B | -1.23B |
| Total Common Equity | 2.97B | 2.99B | 2.99B | 3.18B | 3.05B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.97B | 2.99B | 2.99B | 3.18B | 3.05B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.97B | 2.99B | 2.99B | 3.18B | 3.05B |
|
|
|||||